Amyotrophic lateral sclerosis: translating genetic discoveries into therapies

F Akçimen, ER Lopez, JE Landers, A Nath… - Nature Reviews …, 2023 - nature.com
Recent advances in sequencing technologies and collaborative efforts have led to
substantial progress in identifying the genetic causes of amyotrophic lateral sclerosis (ALS) …

Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy

N Suzuki, A Nishiyama, H Warita, M Aoki - Journal of human genetics, 2023 - nature.com
Amyotrophic lateral sclerosis (ALS) is an intractable disease that causes respiratory failure
leading to mortality. The main locus of ALS is motor neurons. The success of antisense …

Update on genetics of amyotrophic lateral sclerosis

D Brenner, A Freischmidt - Current Opinion in Neurology, 2022 - journals.lww.com
The genetic and molecular basis of ALS is increasingly examined on single-cell resolution.
In the past 2 years, the understanding of the downstream mechanisms of several ALS genes …

Current state and future directions in the diagnosis of amyotrophic lateral sclerosis

M Vidovic, LH Müschen, S Brakemeier, G Machetanz… - Cells, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease characterized by
loss of upper and lower motor neurons, resulting in progressive weakness of all voluntary …

Non-motor symptoms in amyotrophic lateral sclerosis: lessons from Parkinson's disease

A Shojaie, S Rota, A Al Khleifat… - … Lateral Sclerosis and …, 2023 - Taylor & Francis
Amyotrophic lateral sclerosis and Parkinson's disease are neurodegenerative diseases of
the motor system which are now recognized also to affect non-motor pathways. Non-motor …

The role of structural variations in Alzheimer's disease and other neurodegenerative diseases

H Wang, LS Wang, G Schellenberg… - Frontiers in Aging …, 2023 - frontiersin.org
Dozens of single nucleotide polymorphisms (SNPs) related to Alzheimer's disease (AD)
have been discovered by large scale genome-wide association studies (GWASs). However …

Advances in sequencing technologies for amyotrophic lateral sclerosis research

E Udine, A Jain, M van Blitterswijk - Molecular neurodegeneration, 2023 - Springer
Amyotrophic lateral sclerosis (ALS) is caused by upper and lower motor neuron loss and
has a fairly rapid disease progression, leading to fatality in an average of 2-5 years after …

[HTML][HTML] Singling out motor neurons in the age of single-cell transcriptomics

JA Blum, AD Gitler - Trends in Genetics, 2022 - cell.com
Motor neurons are a remarkably powerful cell type in the central nervous system. They
innervate and control the contraction of virtually every muscle in the body and their …

DNA damage, defective DNA repair, and neurodegeneration in amyotrophic lateral sclerosis

A Konopka, JD Atkin - Frontiers in Aging Neuroscience, 2022 - frontiersin.org
DNA is under constant attack from both endogenous and exogenous sources, and when
damaged, specific cellular signalling pathways respond, collectively termed the “DNA …

In silico exploration of metabolically active peptides as potential therapeutic agents against amyotrophic lateral sclerosis

TH Fatoki, S Chukwuejim, CC Udenigwe… - International Journal of …, 2023 - mdpi.com
Amyotrophic lateral sclerosis (ALS) is regarded as a fatal neurodegenerative disease that is
featured by progressive damage of the upper and lower motor neurons. To date, over 45 …